Pyoderma Gangrenosum Associated With Active Chronic Hepatitis
- 1 September 1976
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 112 (9) , 1297-1301
- https://doi.org/10.1001/archderm.1976.01630330059017
Abstract
• In two patients, active chronic hepatitis was complicated by the development of pyoderma gangrenosum. The favorable response of the pyodermatous lesions to azathioprine therapy suggests that this drug may be of value in treating this disorder in patients for whom corticosteroid therapy produces no benefit or is contraindicated because of side effects. Azathioprine, too, is a potentially toxic drug and may need to be discontinued. Possible causal relationships between pyoderma gangrenosum and active chronic hepatitis are discussed. (Arch Dermatol112:1297-1301, 1976)Keywords
This publication has 11 references indexed in Scilit:
- Treatment of polymyositis with immunosuppressive drugsNeurology, 1973
- PYODERMA GANGRENOSUM WITH ALTERED CELLULAR IMMUNITY AND DERMONECROTIC FACTOR*British Journal of Dermatology, 1972
- Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic HepatitisQJM: An International Journal of Medicine, 1971
- PYODERMA GANGRENOSUM WITH A MONOCLONAL IgM RED CELL AGGLOMERATING FACTORBritish Journal of Dermatology, 1971
- A CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISPublished by Elsevier ,1971
- Azathioprine in psoriasis.BMJ, 1970
- Skin lesions in ulcerative colitis.Gut, 1969
- Pyoderma gangrenosum with response to cyclophosphamide therapyThe Journal of Pediatrics, 1967
- Active `juvenile' cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapyGut, 1963
- AUTOANTIBODIES IN HUMAN ULCERATIVE COLITISThe Journal of Experimental Medicine, 1959